BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27858865)

  • 1. Medical care utilization and costs on end-of-life cancer patients: The role of hospice care.
    Chang HT; Lin MH; Chen CK; Chen TJ; Tsai SL; Cheng SY; Chiu TY; Tsai ST; Hwang SJ
    Medicine (Baltimore); 2016 Nov; 95(44):e5216. PubMed ID: 27858865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer.
    Obermeyer Z; Makar M; Abujaber S; Dominici F; Block S; Cutler DM
    JAMA; 2014 Nov; 312(18):1888-96. PubMed ID: 25387186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trend analysis of end-of-life care between hospice and nonhospice groups of cancer patients in Taiwan for 2002-11.
    Chiang JK; Lee YC; Kao YH
    Medicine (Baltimore); 2017 Aug; 96(34):e7825. PubMed ID: 28834888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing costs at the end of life through provider incentives for hospice care: A retrospective cohort study.
    Chen B; Kuo CC; Huang N; Fan VY
    Palliat Med; 2018 Sep; 32(8):1389-1400. PubMed ID: 29793393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Hemodialysis on Terminal Cancer Patients in Hospices: A Nationwide Retrospective Study in Taiwan.
    Kang SC; Lin CC; Chen YC; Wang WS
    J Palliat Med; 2019 Feb; 22(2):188-192. PubMed ID: 30601079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care costs for patients with cancer at the end of life.
    Chastek B; Harley C; Kallich J; Newcomer L; Paoli CJ; Teitelbaum AH
    J Oncol Pract; 2012 Nov; 8(6):75s-80s. PubMed ID: 23598848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and cost of services in the last 6 months of life of patients with cancer - with and without home hospice care.
    Bentur N; Resnizky S; Balicer R; Eilat-Tsanani T
    Am J Hosp Palliat Care; 2014 Nov; 31(7):723-5. PubMed ID: 23928076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and cost-effectiveness of hospice care for metastatic melanoma patients.
    Huo J; Lairson DR; Du XL; Chan W; Buchholz TA; Guadagnolo BA
    Am J Manag Care; 2014 May; 20(5):366-73. PubMed ID: 25181566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in medical costs for end-of-life patients receiving traditional care and those receiving hospice care: A retrospective study.
    Huang YT; Wang YW; Chi CW; Hu WY; Lin R; Shiao CC; Tang WR
    PLoS One; 2020; 15(2):e0229176. PubMed ID: 32078660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospice in end-of-life patients with cancer: does it lead to changes in nonhospice health care utilization after stopping cancer treatment?
    Breitkopf CR; Stephens EK; Jatoi A
    Am J Hosp Palliat Care; 2014 Jun; 31(4):392-5. PubMed ID: 23666617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End of life care for the most common women cancers in Taiwan.
    Pan HJ; Chang HT; Huang WC; Lin HC
    Public Health; 2020 Sep; 186():119-124. PubMed ID: 32818724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer Patients.
    Shao YY; Hsiue EH; Hsu CH; Yao CA; Chen HM; Lai MS; Cheng AL
    Oncologist; 2017 Jul; 22(7):843-849. PubMed ID: 28408618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-of-Life Costs and Hospice Utilization in Patients with Head and Neck Cancer.
    Chen MM; Rosenthal EL; Divi V
    Otolaryngol Head Neck Surg; 2019 Sep; 161(3):439-441. PubMed ID: 31013209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in Taiwan.
    Chiang JK; Kao YH; Lai NS
    PLoS One; 2015; 10(9):e0138773. PubMed ID: 26406871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resource utilization for ovarian cancer patients at the end of life: how much is too much?
    Lewin SN; Buttin BM; Powell MA; Gibb RK; Rader JS; Mutch DG; Herzog TJ
    Gynecol Oncol; 2005 Nov; 99(2):261-6. PubMed ID: 16140364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between End-of-Life Expenditures and Hospice Stay Length Vary by Clinical Condition and Expenditure Duration.
    Hung P; Hsu SH; Wang SY
    Value Health; 2020 Jun; 23(6):697-704. PubMed ID: 32540226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospice shared-care saved medical expenditure and reduced the likelihood of intensive medical utilization among advanced cancer patients in Taiwan--a nationwide survey.
    Lin WY; Chiu TY; Ho CT; Davidson LE; Hsu HS; Liu CS; Chiu CF; Peng CT; Chen CY; Hu WY; Hsu LN; Li CI; Li TC; Lin CY; Chen CY; Lin CC
    Support Care Cancer; 2014 Jul; 22(7):1907-14. PubMed ID: 24570105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographical disparities in treatment and health care costs for end-of-life cancer patients in China: a retrospective study.
    Leng A; Jing J; Nicholas S; Wang J
    BMC Cancer; 2019 Jan; 19(1):39. PubMed ID: 30621633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Hospice Length of Stay, Health Care Utilization, and Medicare Costs at the End of Life Among Patients Who Received Maintenance Hemodialysis.
    Wachterman MW; Hailpern SM; Keating NL; Kurella Tamura M; O'Hare AM
    JAMA Intern Med; 2018 Jun; 178(6):792-799. PubMed ID: 29710217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and Cost of Patients With Terminal Cancer Admitted to Acute Care in the Final 2 Weeks of Life: A Retrospective Chart Review.
    Kyeremanteng K; Ismail A; Wan C; Thavorn K; D'Egidio G
    Am J Hosp Palliat Care; 2019 Nov; 36(11):1020-1025. PubMed ID: 30991816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.